HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.

Abstract
Synthetic peptide vaccines targeting B-cell epitopes of the extracellular domain of the HER-2 oncoprotein were evaluated for their capacity to elicit HER-2-specific antibodies with antiproliferative activity. Several HER-2 B-cell epitopes were identified by computer-aided analysis of protein antigenicity, and selected B-cell epitopes were synthesized colinearly with a promiscuous T-helper epitope (208-302) derived from the measles virus fusion protein at either the NH2 or COOH terminus linked via a four-residue turn sequence (GPSL). In addition, one epitope sequence, 628-647, was mutated to optimize disulfide pairing to mimic the native HER-2 receptor. All of the four selected epitopes elicited high-titered antibodies in outbred rabbits with exceptionally high titers for MVF-HER-2(628-647). These antibodies were cross-reactive with the native HER-2 receptor. Antibodies elicited by MVF HER-2(628-647) inhibited proliferation of human HER-2-overexpressing breast cancer cells in vitro and caused their antibody-dependent cell-mediated cytotoxicity. Furthermore, immunization with MVF-HER-2(628-647) prevented the spontaneous development of HER-2/neu-overexpressing mammary tumors in 83% of transgenic mice. The engineered, chimeric peptide B-cell immunogen MVF-HER-2(628-647) may have applications in the prevention of HER-2-overexpressing cancers.
AuthorsN K Dakappagari, D B Douglas, P L Triozzi, V C Stevens, P T Kaumaya
JournalCancer research (Cancer Res) Vol. 60 Issue 14 Pg. 3782-9 (Jul 15 2000) ISSN: 0008-5472 [Print] United States
PMID10919651 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cancer Vaccines
  • Disulfides
  • Epitopes
  • Peptides
  • Recombinant Fusion Proteins
  • Receptor, ErbB-2
Topics
  • Amino Acid Sequence
  • Animals
  • B-Lymphocytes (immunology)
  • Cancer Vaccines (immunology, therapeutic use)
  • Cell Division (genetics, immunology)
  • Cell Line
  • Disulfides
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes (immunology)
  • Female
  • Humans
  • Leukocytes, Mononuclear (immunology)
  • Mammary Neoplasms, Experimental (genetics, prevention & control)
  • Measles virus (chemistry)
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Peptides (immunology)
  • Point Mutation
  • Protein Conformation
  • Protein Folding
  • Rabbits
  • Rats
  • Receptor, ErbB-2 (genetics)
  • Recombinant Fusion Proteins (metabolism)
  • T-Lymphocytes (immunology)
  • Time Factors
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: